The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique

NCT03820362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2019-01-29

No results posted yet for this study

Summary

Personal identity is being recently recognized as a core element for mental health disorders, with relevant clinical implications. However, scarcity of data exists on its role in schizophrenia and related disorders. The repertory grid (RGT), a technique derived from personal construct theory, has been used in different clinical and non-clinical contexts for the study of the construction perception of self and others, to appreciate aspects of interpersonal construing such as polarization and differentiation (unidimensional thinking) or self-construction.and Our study aims to explore the potential influence of the structure of personal identity and of other relevant cognitive factors (social cognition, metacognition, neurocognition) in positive and negative symptoms in people suffering schizophrenia and related disorders.

Conditions

Sponsors & Collaborators

  • Parc Sanitari Sant Joan de Déu

    collaborator OTHER
  • Agència de Gestió d'Ajuts Universitaris i de Recerca, Catalunya, Spain

    collaborator UNKNOWN
  • Ministerio de Educación y Formación Profesional, Spain

    collaborator UNKNOWN
  • University of Barcelona

    lead OTHER

Principal Investigators

  • Helena García-Mieres, MsC · Universitat de Barcelona & Parc Sanitari Sant Joan de Déu

  • Susana Ochoa, PhD · Parc Sanitari Sant Joan de Déu

  • Guillem Feixas, PhD · University of Barcelona

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03820362 on ClinicalTrials.gov